Stock listing

GNFTF Stock Price, News, Filings & Events — Genfit Sa

Selected listing: GNFTF · OTC · USD · US

GNFTF:OTC represents Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic diseases and liver conditions. The company is actively engaged in clinical trials and research to advance its product pipeline, which includes treatments for non-alcoholic steatohepatitis (NASH) and other related disorders. Recent news highlights Genfit's progress in its studies and collaborations aimed at addressing significant unmet medical needs in the healthcare market. Investors can stay informed through the latest filings and updates regarding the company's strategic initiatives and market developments.

GNFTF:OTCUSDUSUpdated July 24, 2026
Genfit Sa logo
Ticker
GNFTF:OTC
Asset type
Stock
Market cap
$757.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
OTC
Currency
USD

Genfit Sa GNFTF:OTC stock context

GNFTF:OTC represents Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic diseases and liver conditions. The company is actively engaged in clinical trials and research to advance its product pipeline, which includes treatments for non-alcoholic steatohepatitis (NASH) and other related disorders. Recent news highlights Genfit's progress in its studies and collaborations aimed at addressing significant unmet medical needs in the healthcare market. Investors can stay informed through the latest filings and updates regarding the company's strategic initiatives and market developments.

Research Genfit Sa

Alternate listings